xenon xe-129 hyperpolarized · Polarean · NDA 214375
Xenoview
Earliest generic entry, as listed
29 Dec 2035
Blocked by patent: US 11052161.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 11052161 | product | 29 Dec 2035 |
| US 10583205 | product | 20 Feb 2035 |
Exclusivities · 1 unexpired
| NCE | new chemical entity (5 years) | 23 Dec 2027 |
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 214375 · 001 · RLD | gas, inhalation | N/A | 29 Dec 2035 |